These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 25624675

  • 1. Adherence to topical glaucoma medications in Ethiopian patients.
    Tamrat L, Gessesse GW, Gelaw Y.
    Middle East Afr J Ophthalmol; 2015; 22(1):59-63. PubMed ID: 25624675
    [Abstract] [Full Text] [Related]

  • 2. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia.
    Anbesse DH, Yibekal BT, Assefa NL.
    Eur J Ophthalmol; 2019 Mar; 29(2):189-195. PubMed ID: 29747522
    [Abstract] [Full Text] [Related]

  • 3. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
    Mehari T, Giorgis AT, Shibeshi W.
    BMC Ophthalmol; 2016 Aug 02; 16():131. PubMed ID: 27485739
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan.
    Hwang DK, Liu CJ, Pu CY, Chou YJ, Chou P.
    JAMA Ophthalmol; 2014 Dec 02; 132(12):1446-52. PubMed ID: 25211300
    [Abstract] [Full Text] [Related]

  • 7. Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia.
    Melaku MW, Yibekal BT, Demilew KZ.
    PLoS One; 2023 Dec 02; 18(4):e0284200. PubMed ID: 37099553
    [Abstract] [Full Text] [Related]

  • 8. Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.
    Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Quigley HA.
    Ophthalmology; 2009 Jun 02; 116(6):1097-105. PubMed ID: 19376591
    [Abstract] [Full Text] [Related]

  • 9. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: the automated dosing reminder study.
    Boland MV, Chang DS, Frazier T, Plyler R, Friedman DS.
    JAMA Ophthalmol; 2014 Jul 02; 132(7):838-44. PubMed ID: 24830878
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Factors Affecting Adherence to Topical Glaucoma Therapy: A Quantitative and Qualitative Pilot Study Analysis in Sydney, Australia.
    Spencer SKR, Shulruf B, McPherson ZE, Zhang H, Lee MB, Francis IC, Bank A, Coroneo MT, Agar A.
    Ophthalmol Glaucoma; 2019 Jul 02; 2(2):86-93. PubMed ID: 32672609
    [Abstract] [Full Text] [Related]

  • 12. Automated telecommunication-based reminders and adherence with once-daily glaucoma medication dosing: the automated dosing reminder study.
    Boland MV, Chang DS, Frazier T, Plyler R, Jefferys JL, Friedman DS.
    JAMA Ophthalmol; 2014 Jul 02; 132(7):845-50. PubMed ID: 24831037
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.
    Ophthalmology; 2009 Feb 02; 116(2):191-9. PubMed ID: 19084273
    [Abstract] [Full Text] [Related]

  • 15. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM, Bron AM, Creuzot-Garcher CP, Diestelhorst M.
    J Glaucoma; 2011 Oct 02; 20(8):502-8. PubMed ID: 20852438
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Real-world assessment of topical glaucoma medication persistence rates based on national pharmaceutical claim data in a defined population.
    Zhu Z, Jiang Y, Wang W, Scheetz J, Shang X, Zhang L, He M.
    Clin Exp Ophthalmol; 2019 Sep 02; 47(7):881-891. PubMed ID: 31034700
    [Abstract] [Full Text] [Related]

  • 18. Adherence to topical glaucoma medication during hospitalization.
    Yousuf SJ, Jones LS.
    J Glaucoma; 2011 Dec 02; 20(9):573-6. PubMed ID: 21048511
    [Abstract] [Full Text] [Related]

  • 19. Morning dosing of once-daily glaucoma medication is more convenient and may lead to greater adherence than evening dosing.
    Ford BA, Gooi M, Carlsson A, Crichton AC.
    J Glaucoma; 2013 Jan 02; 22(1):1-4. PubMed ID: 21946541
    [Abstract] [Full Text] [Related]

  • 20. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.
    Hermann MM, Papaconstantinou D, Muether PS, Georgopoulos G, Diestelhorst M.
    Acta Ophthalmol; 2011 Jun 02; 89(4):e300-5. PubMed ID: 21106046
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.